Physician profile
Kelsey Eickelman
NPI 1144883661
$6,694.41
in general payments reported to CMS, 2019-2025
19 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $511 · 2022: $559 · 2023: $2,381 · 2024: $2,933 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,624.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,872.40 | 2023-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,361.96 | 2023-2025 | Sunlenca |
| Theratechnologies INC. | $360.98 | 2023-2024 | Egrifta, Trogarzo |
| Abbvie INC. | $320.04 | 2021-2025 | |
| Glaxosmithkline, LLC. | $308.47 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $291.68 | 2022-2025 | Pifeltro, Delstrigo, Dificid |
| Novo Nordisk INC | $218.76 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $211.68 | 2021-2023 | Breztri |
| Amgen INC. | $160.51 | 2021-2025 | Krystexxa |
| Janssen Biotech, INC. | $139.66 | 2023 | Symtuza |
| Lilly USA, LLC | $123.44 | 2021-2024 | Zepbound, Mounjaro |
| Emd Serono, INC. | $84.98 | 2023-2024 | Serostim |
| Napo Pharmaceuticals INC | $74.50 | 2023-2024 | Mytesi |
| Biohaven Pharmaceutical Holding Company LTD. | $42.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.29 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $33.60 | 2023 | Symtuza |
| Redhill Biopharma INC. | $19.84 | 2021 | |
| Exact Sciences Corporation | $18.28 | 2025 | Cologuard Collection Kit |
| Vistapharm, INC. | $14.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Eickelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.